Clinical Trial Update: Lamotrigine in the Treatment of Binge Eating Disorder Associated With Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial of lamotrigine for binge eating disorder associated with obesity has completed. The update does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• Lamotrigine (lamotrigine)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Binge Eating Disorder, Obesity | Phase 3 | Status: COMPLETED